US Biden to outline plans to make vaccine doses more accessible
Josh joust, wing shortage, helping Canada: News from around our 50 states
How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.
WASHINGTON (Reuters) - President Joe Biden will outline his administration's plans to make the COVID-19 vaccine more accessible in the United States during his remarks later on Tuesday, the White House said.
"The president will talk about the preparations we are making," said White House spokeswoman Jen Psaki.
Biden is set to speak around 2:30 p.m. ET (1830 GMT).
More than half of the U.S. adult population has taken one dose of the vaccine, according to the Centers for Disease Control and Prevention. (Graphic on global vaccines: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/)
About 40% of adults are fully vaccinated.
Millions more Americans are expected to become eligible for the shots in the coming months with the expansion of the vaccination effort to include children and adolescents.
The government is also working to overcome skepticism about vaccine usage as it attempts to inoculate most Americans.
Psaki said the federal government will distribute some 29 million doses to states this week.
(Reporting by Nandita Bose and Trevor Hunnicutt; Editing by Chris Reese)
States scale back vaccine orders as interest in shots wanes .
States asked the federal government this week to withhold staggering amounts of COVID-19 vaccine amid plummeting demand for the shots, contributing to a growing U.S. stockpile of doses. From South Carolina to Washington, states are requesting the Biden administration send them only a fraction of what's been allocated to them.From South Carolina to Washington, states are requesting the Biden administration send them only a fraction of what's been allocated to them. The turned-down vaccines amount to hundreds of thousands of doses this week alone, providing a stark illustration of the problem of vaccine hesitancy in the U.S.